Wacker has acquired the manufacturing assets and know-how of US-based Bio Med Sciences to expand its expertise and business in silicone-coated healthcare products. WHO: Since 1987, Bio Med Sciences has been a pioneer with its Silon technology, which blends the best properties of silicone and Teflon, enabling them to develop new and innovative products for wound care, scar management, and skin-renewing technologies. Mark E. Dillon, President & CEO, started Bio Med Sciences based on technology he developed as a university student. The company has secured numerous patents around the world.Founded in 1914, Wacker is a technological leader in the chemical industry and manufactures products for all key global industries. It is active in the silicone, polymer, life sciences, and polysilicon markets. Its portfolio includes more than 3,000 products supplied in over 100 countries.WHY: With the transaction, Wacker advances its expertise for fully integrated development and production of silicone-coated adhesive products. Silicones are best-in-class adhesive solutions due to their skin compatibility and tunable adhesive properties. The skin fixation market for healthcare patches and medical devices has seen a growth trend. Wacker will also use the acquired technology to develop innovations in stick-to-skin applications, such as wearable medical devices and scar care.IN THEIR OWN WORDS: "The acquisition is an important step for us. Now, we have the capability to drive forward our business with silicone specialties with even greater vigor," said Christian Kirsten, a member of the Wacker Board.